Cearvol Diamond X1 vs Resound Vivia 9 60S microRIE

The Cearvol Diamond X1 is a budget-priced OTC hearing aid available for $199, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This visible-in-ear style device ranks #30 among 65 OTC hearing aids tested, placing it in the top 45% of its category. The Diamond X1 delivers a mixed performance profile with one notable strength: music streaming. With a score of 4.1/5, it performs 2.18 points above the category average—a substantial margin that makes it appealing for users who value audio entertainment through their hearing aids. Feedback handling is excellent at 4.5/5, providing stable performance during typical daily movements. Both iPhone and Android streaming are supported with rechargeable batteries for convenience. Speech performance presents a more modest picture. Speech in quiet scores 2.8/5, which is above the category average but only mixed in absolute terms. Speech in noise measures 1.7/5—above the category average of 1.48/5, though still low overall. Own-voice comfort is a weakness at 1.7/5, falling 0.81 points below the category average, which may cause your own voice to sound unnatural or boomy. The Diamond X1 is best suited for budget-conscious consumers who prioritize music and media streaming over maximum speech clarity. Those seeking stronger speech performance in challenging listening environments may want to consider higher-scoring alternatives in this price range, such as the Elehear Beyond or Apple AirPods Pro 2.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.